BBHC developed the world's only side-effect-free pluripotent stem cells (nEPS) and succeeded in differentiating human pancreatic beta cells, hepatocytes, nerve cells, cartilage cells, osteoblasts, kidney cells, hematopoietic stem cells, and heart cells using this. In this regard, more than 470 patents are being registered in 147 countries, of which 309 patents have been registered in the US, EU, Israel, Australia, Singapore, and Japan, including Korea.